CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-28 | Pauls Dietrich John President and CEO | Grant or award · Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2021-07-28 | Kellen Scott CFO and Secretary | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2021-07-15 | Giuffre Randall Michael Director | Grant or award · Stock Option (right to buy) | +9,393 | 9,393 | ||
| 2021-07-15 | Parsons James T. Director | Grant or award · Stock Option (right to buy) | +9,393 | 9,393 | ||
| 2021-07-15 | Pilnik Richard D. Director | Grant or award · Stock Option (right to buy) | +13,150 | 13,150 | ||
| 2021-07-15 | Burroughs Amy L. Director | Grant or award · Stock Option (right to buy) | +18,786 | 18,786 | ||
| 2021-07-15 | Semba Charles Pauling Director | Grant or award · Stock Option (right to buy) | +18,786 | 18,786 | ||
| 2021-01-01 | Giuffre Randall Michael Director | Grant or award | +7,441 | $8.23 | $61K | 116,029 |
| 2021-01-01 | Parsons James T. Director | Grant or award | +7,745 | $8.23 | $64K | 21,947 |
| 2021-01-01 | Pilnik Richard D. Director | Grant or award | +9,719 | $8.23 | $80K | 80,565 |
| 2020-12-04 | Pilnik Richard D. Director | Purchase | +5,000 | $5.50 | $27K | 65,846 |
| 2020-12-04 | Pilnik Richard D. Director | Purchase | +5,000 | $5.24 | $26K | 70,846 |
| 2020-11-20 | Giuffre Randall Michael Director | Purchase | +15,000 | $4.26 | $64K | 108,588 |
| 2020-11-09 | Kellen Scott CFO and Secretary | Purchase | +2,000 | $4.19 | $8K | 12,290 |
| 2020-06-01 | Gilman Sydney A. VP, Regulatory Affairs | Grant or award · Stock Option (right to buy) | +17,500 | 17,500 | ||
| 2020-06-01 | Kellen Scott CFO and Secretary | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2020-06-01 | Pauls Dietrich John President and CEO | Grant or award · Stock Option (right to buy) | +56,000 | 56,000 | ||
| 2020-06-01 | ALCORN HARRY W JR Chief Medical Officer | Grant or award · Stock Option (right to buy) | +35,000 | 35,000 | ||
| 2020-06-01 | Giuffre Randall Michael Director | Grant or award | +7,784 | $4.59 | $36K | 93,588 |
| 2020-06-01 | Giuffre Randall Michael Director | Grant or award · Stock Option (right to buy) | +13,306 | 13,306 |
Page 8 of 10 · 189 trades